Skip to main content
. Author manuscript; available in PMC: 2012 Nov 25.
Published in final edited form as: J Mol Cell Cardiol. 2005 Oct 19;39(6):865–873. doi: 10.1016/j.yjmcc.2005.09.007

Fig. 5.

Fig. 5

Antibody blocking of growth factor receptors. H7 human ES cells were differentiated for 20 days before Percoll separation, and fraction IV cells were cultured for an additional 4 days in serum-free media with various signaling inhibitors. The inhibitors were added for the final 48 hours of culture prior to fixation. Only the PI 3-kinase inhibitor (LY294002) and the IGF-1 receptor blocking antibody significantly inhibited human ES cell-derived cardiomyocyte proliferation (* = P < 0.05), whereas antibodies to the EPO ligand or receptor had no effect.

HHS Vulnerability Disclosure